[HTML][HTML] IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein
VN Uversky, EM Redwan, W Makis, A Rubio-Casillas - Vaccines, 2023 - mdpi.com
Less than a year after the global emergence of the coronavirus SARS-CoV-2, a novel
vaccine platform based on mRNA technology was introduced to the market. Globally, around …
vaccine platform based on mRNA technology was introduced to the market. Globally, around …
Pertussis re-emergence in the post-vaccination era
E Chiappini, A Stival, L Galli, M De Martino - BMC infectious diseases, 2013 - Springer
Background Resurgence of pertussis in the post-vaccination era has been reported in
Western countries. A shift of cases from school-age children to adolescents, adults and …
Western countries. A shift of cases from school-age children to adolescents, adults and …
Key steps in vaccine development
PL Stern - Annals of Allergy, Asthma & Immunology, 2020 - Elsevier
Objective The goal of a vaccine is to prime the immune response so the immune memory
can facilitate a rapid response to adequately control the pathogen on natural infection and …
can facilitate a rapid response to adequately control the pathogen on natural infection and …
Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis
Many countries continue to experience pertussis epidemics despite widespread vaccination.
Waning protection after booster vaccination has highlighted the need for a better …
Waning protection after booster vaccination has highlighted the need for a better …
Immune persistence after pertussis vaccination
Z Chen, Q He - Human vaccines & immunotherapeutics, 2017 - Taylor & Francis
Pertussis is one of the most prevalent vaccine-preventable diseases worldwide. The true
infection rate is significantly higher than the reported incidence rate. An increased …
infection rate is significantly higher than the reported incidence rate. An increased …
Safety of Tdap vaccine in pregnant women: an observational study
Objectives Actively recruit and intensively follow pregnant women receiving a dose of
acellular pertussis vaccine for 4 weeks after vaccination. Design and settings A prospective …
acellular pertussis vaccine for 4 weeks after vaccination. Design and settings A prospective …
Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
HJ Lee, JH Choi - Clinical and experimental vaccine …, 2017 - synapse.koreamed.org
Although tetanus and diphtheria have become rare in developed countries, pertussis is still
endemic in some developed countries. These are vaccine-preventable diseases and …
endemic in some developed countries. These are vaccine-preventable diseases and …
Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion Maternal Vaccine Coadministered With Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study
N Hermida, M Ferguson, I Leroux-Roels… - The Journal of …, 2023 - academic.oup.com
Background Respiratory syncytial virus (RSV) fusion protein stabilized in the prefusion
conformation (RSVPreF3) was under investigation as a maternal vaccine. Methods This …
conformation (RSVPreF3) was under investigation as a maternal vaccine. Methods This …
Factors influencing women's decisions about having the pertussis-containing vaccine during pregnancy
ABSTRACT INTRODUCTION New Zealand experienced a major epidemic of pertussis from
September 2011 to January 2014. In response to this epidemic, a pertussis-containing …
September 2011 to January 2014. In response to this epidemic, a pertussis-containing …
Immunopharmacotherapeutic advancements in addressing methamphetamine abuse
JC Lee, KD Janda - RSC Chemical Biology, 2021 - pubs.rsc.org
Methamphetamine (METH) is an illicit psychostimulant that is known to account for
substance abuse disorders globally, second only to opioids, yet has no approved …
substance abuse disorders globally, second only to opioids, yet has no approved …